Wednesday, January 13, 2016
ACADIA Pharmaceuticals Adds Board Member
San Diego-based biopharmaceuticals developer ACADIA Pharmaceuticals said earlier this week that it has added a new member to its board of directors. ACADIA said it appointed Jim Daly, the former Executive Vice President and Chief Commercial Officer at Incyte Corporation to the board. Daly also served at Amgen, having service as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development, among other positions; he also served at Glaxo Wellcome/GlaxoSmithKline. Daly is also on the board of Chimerix.